Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-12 4:35 pm Sale | 2025-12-31 | 13G | CYPHERPUNK TECHNOLOGIES INC. C CYPH | GILEAD SCIENCES INC. GILD | 0 0.000% | -5,319,148 (Position Closed) | Filing History |
| 2025-11-21 4:16 pm Unchanged | 2025-10-08 | 13D | CYPHERPUNK TECHNOLOGIES INC. C CYPH | Winklevoss Capital Fund, LLC | 12,084,463 19.900% | 0 (Unchanged) | Filing History |
| 2025-11-18 4:31 pm Purchase | 2025-11-12 | 13G | CYPHERPUNK TECHNOLOGIES INC. C CYPH | Severns Sean Michael | 6,000,000 10.590% | 6,000,000 (New Position) | Filing History |
| 2025-10-16 8:25 pm Purchase | 2025-10-08 | 13D | CYPHERPUNK TECHNOLOGIES INC. C CYPH | Winklevoss Capital Fund, LLC | 12,084,463 19.900% | 12,084,463 (New Position) | Filing History |
| 2025-08-14 5:28 pm Sale | 2025-06-30 | 13G | CYPHERPUNK TECHNOLOGIES INC. C CYPH | Samsara BioCapital, L.P. | 0 0.000% | -2,442,352 (Position Closed) | Filing History |
| 2025-02-14 06:22 am Sale | 2024-12-31 | 13G | CYPHERPUNK TECHNOLOGIES INC. C CYPH | Balyasny Asset Management L.P. | 0 0.000% | -3,085,104 (Position Closed) | Filing History |
| 2024-11-14 06:07 am Purchase | 2024-09-30 | 13G | CYPHERPUNK TECHNOLOGIES INC. C CYPH | Balyasny Asset Management L.P. | 3,085,104 8.060% | 3,085,104 (New Position) | Filing History |
| 2024-10-31 6:29 pm Unchanged | 2024-10-31 | 13D | CYPHERPUNK TECHNOLOGIES INC. C CYPH | BeOne Medicines Ltd. ONC | 1,215,306 3.170% | 0 (Unchanged) | Filing History |
| 2024-10-31 5:40 pm Sale | 2024-10-31 | 13D | CYPHERPUNK TECHNOLOGIES INC. C CYPH | BeOne Medicines Ltd. ONC | 1,215,306 0.000% | -1 (-0.00%) | Filing History |
| 2024-04-25 8:39 pm Purchase | 2024-04-15 | 13G | LEAP THERAPEUTICS INC LPTX | Samsara BioCapital, L.P. | 2,442,352 6.400% | 2,442,352 (New Position) | Filing History |
| 2024-04-19 4:31 pm Purchase | 2024-04-10 | 13G | LEAP THERAPEUTICS INC LPTX | GILEAD SCIENCES INC. GILD | 5,319,148 13.900% | 5,319,148 (New Position) | Filing History |
| 2024-02-14 4:40 pm Purchase | 2023-12-31 | 13G | CYPHERPUNK TECHNOLOGIES INC. C CYPH | Perceptive Advisors LLC | 1,068,497 4.000% | 395,847 (+58.85%) | Filing History |
| 2023-02-14 2:30 pm Sale | 2022-12-31 | 13G | LEAP THERAPEUTICS INC LPTX | Perceptive Advisors LLC | 672,650 6.800% | -175,000 (-20.65%) | Filing History |
| 2022-02-14 6:55 pm Unchanged | 2021-12-31 | 13G | LEAP THERAPEUTICS INC LPTX | Perceptive Advisors LLC | 847,650 9.600% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:05 pm Sale | 2021-12-31 | 13G | LEAP THERAPEUTICS INC LPTX | HHLR ADVISORS LTD. | 0 0.000% | -371,624 (Position Closed) | Filing History |
| 2022-02-11 06:30 am Purchase | 2021-12-31 | 13G | LEAP THERAPEUTICS INC LPTX | Artal International S.C.A. | 400,000 4.500% | 100,000 (+33.33%) | Filing History |
| 2022-02-10 4:16 pm Purchase | 2021-12-31 | 13G | AVIDITY BIOSCIENCES INC RNAM | ELI LILLY & Co LLY | 3,151,605 3.500% | 832,209 (+35.88%) | Filing History |
| 2021-09-28 6:58 pm Purchase | 2021-09-24 | 13D | LEAP THERAPEUTICS INC LPTX | BeOne Medicines Ltd. ONC | 1,215,307 13.200% | 254,380 (+26.47%) | Filing History |